World Equity Group, Inc. Edwards Lifesciences Corp Transaction History

World Equity Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 22, 2024	BUY	$61.71 - $77.76 $72,324 - $91,134	1,172 Added 16.53%	8,264 $630 Million
Q3 2023 Jul 22, 2024	BUY	$69.28 - $93.38 $491,333 - $662,250	7,092 New	7,092 $491 Million
Q2 2023 Aug 26, 2024	SELL	$81.41 - $94.33 $12.8 Million - $14.8 Million	-156,686 Reduced 97.47%	4,069 $384 Million
Q1 2023 Aug 26, 2024	BUY	$74.26 - $84.51 $11.9 Million - $13.6 Million	160,755 New	160,755 $1.44 Billion
Q4 2022 Sep 06, 2024	SELL	$68.3 - $87.44 $21,514 - $27,543	-315 Reduced 7.07%	4,138 $309 Million
Q3 2022 Sep 06, 2024	BUY	$82.37 - $107.29 $366,793 - $477,762	4,453 New	4,453 $368 Million
Q2 2022 Sep 06, 2024	BUY	$86.5 - $128.27 $217,461 - $322,470	2,514 New	2,514 $239 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.